Neurones S.A. (EPA:NRO)
France · Delayed Price · Currency is EUR 36.35
+0.10 (0.28%)
Sep 11, 2026, 5:35 PM CET
Neurones Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 887.68 | 857.18 | 810.35 | 741.18 | 665.38 | 579.88 | |
Revenue Growth | 6.67% | 5.78% | 9.33% | 11.39% | 14.74% | 10.56% |
Cost of Revenue | 438.81 | 438.81 | 421.59 | 394.42 | 356.26 | 323.3 |
Gross Profit | 448.87 | 418.37 | 388.76 | 346.76 | 309.12 | 256.58 |
Selling, General & Admin | 315.98 | 315.98 | 287.11 | 248.58 | 215 | 174.75 |
Amortization of Goodwill & Intangibles | 9.88 | 9.88 | 9.09 | 8.02 | 7.35 | 7.65 |
Other Operating Expenses | 32.72 | 8.82 | 6.62 | 7.58 | 6.49 | 5.38 |
Operating Expenses | 366.68 | 342.78 | 310.93 | 272.06 | 236.89 | 194.93 |
Operating Income | 82.18 | 75.58 | 77.83 | 74.69 | 72.22 | 61.64 |
Interest Expense | -1.76 | -1.76 | -1.82 | -1.43 | -1.7 | -0.97 |
Interest & Investment Income | 10.78 | 10.88 | 11.85 | 5.92 | 1.66 | 1.15 |
Other Non Operating Income (Expenses) | 0.23 | 0.23 | 0 | - | -0.02 | - |
EBT Excluding Unusual Items | 91.43 | 84.93 | 87.86 | 79.18 | 72.16 | 61.83 |
Gain (Loss) on Sale of Investments | 0.14 | 0.14 | 0.16 | 0.43 | 0.03 | 0 |
Gain (Loss) on Sale of Assets | - | - | 0.03 | 0.83 | 0.06 | -0.3 |
Other Unusual Items | 0 | 0 | 0.07 | 0.33 | 0.61 | 0.23 |
Pretax Income | 91.57 | 85.07 | 88.11 | 80.77 | 72.86 | 61.76 |
Income Tax Expense | 25.32 | 23.22 | 24.88 | 22.18 | 21.09 | 18.82 |
Earnings From Continuing Operations | 66.26 | 61.86 | 63.23 | 58.58 | 51.77 | 42.94 |
Minority Interest in Earnings | -10.98 | -9.78 | -10.67 | -9.17 | -7.53 | -5.23 |
Net Income | 55.27 | 52.07 | 52.56 | 49.41 | 44.24 | 37.71 |
Net Income to Common | 55.27 | 52.07 | 52.56 | 49.41 | 44.24 | 37.71 |
Net Income Growth | 8.94% | -0.92% | 6.37% | 11.68% | 17.34% | 21.95% |
Shares Outstanding (Basic) | - | 24 | 24 | 24 | 24 | 24 |
Shares Outstanding (Diluted) | - | 24 | 24 | 24 | 24 | 24 |
Shares Change | - | 0.13% | 0.14% | 0.10% | 0.18% | -0.13% |
EPS (Basic) | - | 2.14 | 2.17 | 2.04 | 1.83 | 1.56 |
EPS (Diluted) | - | 2.14 | 2.16 | 2.03 | 1.82 | 1.55 |
EPS Growth | - | -0.93% | 6.40% | 11.54% | 17.42% | 22.05% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | 60.84 | 72.35 | 54.09 | 44.36 | 57.92 |
Free Cash Flow Per Share | - | 2.50 | 2.97 | 2.23 | 1.83 | 2.39 |
Dividend Per Share | - | 1.400 | 1.300 | 1.200 | 1.100 | 1.000 |
Dividend Growth | - | 7.69% | 8.33% | 9.09% | 10.00% | - |
Gross Margin | 50.57% | 48.81% | 47.97% | 46.78% | 46.46% | 44.25% |
Operating Margin | 9.26% | 8.82% | 9.60% | 10.08% | 10.85% | 10.63% |
Profit Margin | 6.23% | 6.08% | 6.49% | 6.67% | 6.65% | 6.50% |
Free Cash Flow Margin | - | 7.10% | 8.93% | 7.30% | 6.67% | 9.99% |
EBITDA | 94.6 | 87.03 | 87.37 | 82.72 | 79.57 | 69.42 |
EBITDA Margin | 10.66% | 10.15% | 10.78% | 11.16% | 11.96% | 11.97% |
D&A For EBITDA | 12.42 | 11.45 | 9.54 | 8.02 | 7.35 | 7.78 |
EBIT | 82.18 | 75.58 | 77.83 | 74.69 | 72.22 | 61.64 |
EBIT Margin | 9.26% | 8.82% | 9.60% | 10.08% | 10.85% | 10.63% |
Effective Tax Rate | 27.64% | 27.29% | 28.24% | 27.47% | 28.95% | 30.47% |
Revenue as Reported | 857.18 | 857.18 | 810.35 | 741.18 | 665.38 | 579.88 |